BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11830759)

  • 1. SB-236057-A: a selective 5-HT1B receptor inverse agonist.
    Roberts C; Watson J; Price GW; Middlemiss DN
    CNS Drug Rev; 2001; 7(4):433-44. PubMed ID: 11830759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig.
    Roberts C; Hatcher P; Hagan JJ; Austin NE; Jeffrey P; Wyman P; Gaster LM; Routledge C; Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):177-83. PubMed ID: 10961381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.
    Middlemiss DN; Göthert M; Schlicker E; Scott CM; Selkirk JV; Watson J; Gaster LM; Wyman P; Riley G; Price GW
    Eur J Pharmacol; 1999 Jun; 375(1-3):359-65. PubMed ID: 10443589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
    Roberts C; Boyd DF; Middlemiss DN; Routledge C
    Neuropharmacology; 1999 Sep; 38(9):1409-19. PubMed ID: 10471095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain.
    Thomas DR; Soffin EM; Roberts C; Kew JN; de la Flor RM; Dawson LA; Fry VA; Coggon SA; Faedo S; Hayes PD; Corbett DF; Davies CH; Hagan JJ
    Neuropharmacology; 2006 Sep; 51(3):566-77. PubMed ID: 16846620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM; Blaney FE; Davies S; Duckworth DM; Ham P; Jenkins S; Jennings AJ; Joiner GF; King FD; Mulholland KR; Wyman PA; Hagan JJ; Hatcher J; Jones BJ; Middlemiss DN; Price GW; Riley G; Roberts C; Routledge C; Selkirk J; Slade PD
    J Med Chem; 1998 Apr; 41(8):1218-35. PubMed ID: 9548813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
    Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
    Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
    Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig.
    Roberts C; Price GW; Gaster L; Jones BJ; Middlemiss DN; Routledge C
    Neuropharmacology; 1997; 36(4-5):549-57. PubMed ID: 9225280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
    Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW
    Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
    Pullar IA; Boot JR; Broadmore RJ; Eyre TA; Cooper J; Sanger GJ; Wedley S; Mitchell SN
    Eur J Pharmacol; 2004 Jun; 493(1-3):85-93. PubMed ID: 15189767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic paroxetine treatment on 5-HT1B and 5-HT1D autoreceptors in rat dorsal raphe nucleus.
    Davidson C; Stamford JA
    Neurochem Int; 2000 Feb; 36(2):91-6. PubMed ID: 10676872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions.
    Roberts C; Belenguer A; Middlemiss DN; Routledge C
    Eur J Pharmacol; 1998 Apr; 346(2-3):175-80. PubMed ID: 9652357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of 5-HT1B receptors causes hypothermia in the guinea pig.
    Hagan JJ; Slade PD; Gaster L; Jeffrey P; Hatcher JP; Middlemiss DN
    Eur J Pharmacol; 1997 Jul; 331(2-3):169-74. PubMed ID: 9274976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M; Fink K; Böing C; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo.
    Rollema H; Clarke T; Sprouse JS; Schulz DW
    J Neurochem; 1996 Nov; 67(5):2204-7. PubMed ID: 8863532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.
    Scott C; Langmead CJ; Clarke KL; Wyman P; Smith PW; Starr KR; Dawson LA; Price GW; Hagan JJ; Watson J
    Neuropharmacology; 2006 Jun; 50(8):984-90. PubMed ID: 16546225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.